451
Views
13
CrossRef citations to date
0
Altmetric
Review

Clinical Utility of Pegaspargase in Children, Adolescents and Young Adult Patients with Acute Lymphoblastic Leukemia: A Review

, , & ORCID Icon
Pages 25-40 | Published online: 19 Apr 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Krishna R Juluri, Chloe Siu & Ryan D Cassaday. (2022) Asparaginase in the Treatment of Acute Lymphoblastic Leukemia in Adults: Current Evidence and Place in Therapy. Blood and Lymphatic Cancer: Targets and Therapy 12, pages 55-79.
Read now

Articles from other publishers (12)

Samy A. Azer & Aya A. Alsharafi. (2023) Can pharmacy students use Wikipedia as a learning resource? Critical assessment of articles on chemotherapeutic drugs. Advances in Physiology Education 47:2, pages 333-345.
Crossref
Ying Zhang, Rukhsora D. Sultonova, Sung-Hwan You, Yoonjoo Choi, So-young Kim, Wan-Sik Lee, Jihyoun Seong, Jung-Joon Min & Yeongjin Hong. (2023) The anticancer effect of PASylated calreticulin-targeting L-ASNase in solid tumor bearing mice with immunogenic cell death-inducing chemotherapy. Biochemical Pharmacology 210, pages 115473.
Crossref
Josep-Maria Ribera. (2023) JZP458 closes the asparaginase allergy gap. Blood 141:7, pages 685-686.
Crossref
Luke Maese, Mignon L. Loh, Mi Rim Choi, Tong Lin, Etsuko Aoki, Michelle Zanette, Shirali Agarwal, Robert Iannone, Jeffrey A. Silverman, Lewis B. Silverman, Elizabeth A. Raetz & Rachel E. Rau. (2023) Recombinant Erwinia asparaginase (JZP458) in acute lymphoblastic leukemia: results from the phase 2/3 AALL1931 study . Blood 141:7, pages 704-712.
Crossref
Todd William MuddJr.Jr., Ashley Danielle Fox, Mark Ghaly & Amany Keruakous. (2023) Case report: Hyperosmolar hyperglycemic syndrome secondary to PEG-asparaginase-induced hypertriglyceridemia and pancreatitis. Frontiers in Oncology 12.
Crossref
Bingqing Tang, Zihong Cai, Zhixiang Wang, Dainan Lin, Xianjun He, Qiuli Li, Xiaojie Liang, Kangyu Huang, Xuan Zhou, Ren Lin, Na Xu, Zhiping Fan, Fen Huang, Jing Sun, Xiaoli Liu, Qifa Liu & Hongsheng Zhou. (2022) Allogeneic hematopoietic stem cell transplantation overcome the poor prognosis of patients with IKZF1plus CD20–a very high-risk subtype in B-cell acute lymphoblastic leukemia. Bone Marrow Transplantation 57:12, pages 1751-1757.
Crossref
Adriana Krupa, Johan de Vos, Lynn Van Eetvelde & Erik Teske. (2022) Pegylated asparaginase in feline high-grade lymphoma: clinical results of single injection and continued incorporation into a modified COP regimen. Journal of Feline Medicine and Surgery 24:8, pages e203-e213.
Crossref
Xiaoting Shan, Xiang Gong, Jie Li, Jingyuan Wen, Yaping Li & Zhiwen Zhang. (2022) Current approaches of nanomedicines in the market and various stage of clinical translation. Acta Pharmaceutica Sinica B 12:7, pages 3028-3048.
Crossref
Umeshreddy V Devarapalli, Moinak S Sarma & Gopinathan Mathiyazhagan. (2022) Gut and liver involvement in pediatric hematolymphoid malignancies. World Journal of Gastrointestinal Oncology 14:3, pages 587-606.
Crossref
Maaike Van Trimpont, Evelien Peeters, Yanti De Visser, Amanda M. Schalk, Veerle Mondelaers, Barbara De Moerloose, Arnon Lavie, Tim Lammens, Steven Goossens & Pieter Van Vlierberghe. (2022) Novel Insights on the Use of L-Asparaginase as an Efficient and Safe Anti-Cancer Therapy. Cancers 14:4, pages 902.
Crossref
М. В. Минасян, А. Г. Закарян, Л. М. Крмоян, М. С. Гижларян, С. О. Данелян & Л. А. Вагаршакян. (2022) L-аспарагиназa. Medical Science of Armenia 62:2, pages 31-37.
Crossref
Larry R. Brown. 2022. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays 1 27 .